DealsOct 27, 2026, 08:21 AM
CDT Equity Inc. Partners with Manoira for Animal Health Asset Evaluation
AI Summary
CDT Equity Inc. has entered into an Evaluation Agreement with Manoira Corporation, a specialty animal health company. Under this agreement, Manoira will assess CDT's clinical-stage compounds AZD1656 and AZD5904 to determine their potential to enhance Manoira's upcoming animal health products. As part of the agreement, CDT issued 1,347,616 shares of its common stock to Manoira, valued at $195,000. The filing also disclosed unregistered sales of equity securities, including shares issued to a service provider, Sarborg Limited, and severance shares issued to former CEO Dr. Andrew Regan.
Key Highlights
- CDT Equity Inc. entered an Evaluation Agreement with Manoira Corporation to assess clinical-stage compounds AZD1656 and AZD5904 for animal healthcare applications.
- Manoira will evaluate CDT's assets to determine if they can improve efficacy, safety, or formulation of Manoira's forthcoming animal health products.
- CDT issued 1,347,616 shares to Manoira valued at $195,000 as payment for the evaluation services.
- CDT also issued 397,374 shares to a service provider and 437,779 shares to Sarborg Limited for consulting and prior agreements.
- Dr. Andrew Regan, former CEO of CDT, received 499,616 shares as severance compensation.
Price Impact
More from CDT